Sadra Medical (Campbell, CA) a clinical-stage device company focused on minimally invasive percutaneous aortic valve replacement, closed a $30M Series C financing. Participants include Accuitive Medical Ventures, Boston Scientific, Finistere Ventures, Firstmark Capital, Oakwood, Onset Ventures and SV Life Sciences.